首页> 外文期刊>American Journal of Physiology >Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia
【24h】

Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia

机译:线粒体基质金属蛋白酶激活降低高同型半胱氨酸血症的心肌细胞收缩力

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

First published June 20, 2008; doi:10.1152/ajpheart.00099.2008.-Cardio-myocyte W-methyl-D-aspartate receptor-1 (NMDA-R1) activation induces mitochondrial dysfunction. Matrix metalloproteinase protease (MMP) induction is a negative regulator of mitochondrial function. Elevated levels of homocysteine [hyperhomocysteinemia (HHCY)] activate latent MMPs and causes myocardial contractile abnormalities. HHCY is associated with mitochondrial dysfunction. We tested the hypothesis that HHCY activates myocyte mitochondrial MMP (mtMMP), induces mitochondrial permeability transition (MPT), and causes contractile dysfunction by agonizing NMDA-R1. The C57BI76J mice were administered homocystinemia (1,8 g/1) in drinking water to induce HHCY. NMDA-R1 expression was detected by Western blot and confocal microscopy. Localization of MMP-9 in the mitochondria was determined using confocal microscopy. Ultrastructural analysis of the isolated myocyte was determined by electron microscopy. Mitochondrial permeability was measured by a decrease in light absor-bance at 540 nm using the spectrophotometer. The effect of MK-801 (NMDA-R1 inhibitor), GM-6001 (MMP inhibitor), and cyclosporine A (MPT inhibitor) on myocyte contractiUty and calcium transients was evaluated using the IonOptix video edge track detection system and fura 2-AM. Our results demonstrate that HHCY activated the mtMMP-9 and caused MPT by agonizing NMDA-R1. A significant decrease in percent cell shortening, maximal rate of contraction (-dL/df), and maximal rate of relaxation (+dL/df) was observed in HHCY. The decay of calcium transient amplitude was faster in the wild type compared with HHCY. Furthermore, the HHCY-induced decrease in percent cell shortening, -dL/df, and +dUdt was attenuated in the mice treated with MK-801, GM-6001, and cyclosporin A. We conclude that HHCY activates mtMMP-9 and induces MPT, leading to myocyte mechanical dysfunction by agonizing NMDA-R1.
机译:首次发布于2008年6月20日; doi:10.1152 / ajpheart.00099.2008.-心肌细胞W-甲基-D-天冬氨酸受体1(NMDA-R1)的激活会诱导线粒体功能障碍。基质金属蛋白酶蛋白酶(MMP)诱导是线粒体功能的负调节剂。高半胱氨酸[高同型半胱氨酸血症(HHCY)]水平升高会激活潜在的MMP,并引起心肌收缩异常。 HHCY与线粒体功能障碍有关。我们测试了HHCY激活肌细胞线粒体MMP(mtMMP),诱导线粒体通透性转变(MPT)并通过激动NMDA-R1引起收缩功能障碍的假说。对C57BI76J小鼠在饮用水中给予高半胱氨酸血症(1.8 g / 1),以诱导HHCY。通过蛋白质印迹和共聚焦显微镜检测NMDA-R1表达。使用共聚焦显微镜确定MMP-9在线粒体中的定位。通过电子显微镜确定分离的心肌细胞的超微结构分析。使用分光光度计,通过降低540 nm处的光吸收率来测量线粒体通透性。使用IonOptix视频边缘跟踪检测系统和fura 2-AM,评估了MK-801(NMDA-R1抑制剂),GM-6001(MMP抑制剂)和环孢菌素A(MPT抑制剂)对心肌细胞收缩和钙瞬变的影响。我们的结果表明,HHCY通过激动NMDA-R1激活mtMMP-9并引起MPT。在HHCY中观察到细胞缩短百分比,最大收缩率(-dL / df)和最大松弛率(+ dL / df)的显着降低。与HHCY相比,野生型中钙瞬变幅度的衰减更快。此外,在用MK-801,GM-6001和环孢菌素A处理的小鼠中,HHCY诱导的细胞缩短百分数,-dL / df和+ dUdt的减少被减弱。我们得出结论,HHCY激活mtMMP-9并诱导MPT。 ,通过激动NMDA-R1导致肌细胞机械功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号